 |
Monday November 2nd, 79 stock ideas |
| New investor letters |
| Lost in Generation AAK $4.7B LFABF $13B NSIS-B $29B RTOBF $13B VIMGF $2.2B |
| November 2026 Update |
| 5Perspectives Large Growth Commentary CRWD $267B META $1.6T MSFT $3.9T MU $946B NET $109B TSLA $1.6T |
| 5Perspectives Small-Mid Growth Commentary BWXT $13B EMBJ $13B LASR $2.1B TWLO $31B TWST $11B WULF $5.4B |
| 5Perspectives Small Growth Commentary BKD $2.5B FIVN $2.7B LASR $2.1B RNG $7.2B TWST $11B WULF $5.4B |
| Technology and AI |
|
|
|
 | Palantir Q3 FY12/26 Earnings Review Palantir reported Q3 revenue of $2.31 billion, up 96%, and raised full-year guidance, while total contract value grew 6% and U.S. commercial bookings slowed sharply. |
|
|
|
| Consumer Discretionary |
|
|
|
|
|
| Financials |
|
| |
|
|
|
|
| Energy |
|
|
| Healthcare |
|
 | BMRN Earnings Review BioMarin’s Q3 revenue rose 32% to $1.02 billion after the Amicus acquisition, while lower 2026 guidance and $2.8 billion of net debt weighed on earnings. |
|
|
|
| Communication Services |
|
|
|
|
|
|
| Consumer Staples |
|
|
| Industrials |
|
|
|
|
|
| Materials |
|
|
|
| Real Estate |
|
|
|
|
|
| Utilities |
|
|
|
| More investor letters |
| Letter 2026 Q3 | 499 KB 0OPN ALFLE $117M BOIVF $12B CEVMF $6.8B CIRSA $3.4B LOTMY $6.7B VARRY $15B |
|